Pathophysiology and treatment of cerebral edema in traumatic brain injury

RM Jha, PM Kochanek, JM Simard - Neuropharmacology, 2019 - Elsevier
Cerebral edema (CE) and resultant intracranial hypertension are associated with
unfavorable prognosis in traumatic brain injury (TBI). CE is a leading cause of in-hospital …

Pathophysiological responses and roles of astrocytes in traumatic brain injury

S Michinaga, Y Koyama - International journal of molecular sciences, 2021 - mdpi.com
Traumatic brain injury (TBI) is immediate damage caused by a blow to the head resulting
from traffic accidents, falls, and sporting activity, which causes death or serious disabilities in …

Sulfonylurea receptor 1 in central nervous system injury: an updated review

RM Jha, A Rani, SM Desai, S Raikwar… - International journal of …, 2021 - mdpi.com
Sulfonylurea receptor 1 (SUR1) is a member of the adenosine triphosphate (ATP)-binding
cassette (ABC) protein superfamily, encoded by Abcc8, and is recognized as a key mediator …

[HTML][HTML] The medical management of cerebral edema: past, present, and future therapies

MR Halstead, RG Geocadin - Neurotherapeutics, 2019 - Elsevier
Cerebral edema is commonly associated with cerebral pathology, and the clinical
manifestation is largely related to the underlying lesioned tissue. Brain edema usually …

Neuropharmacology in traumatic brain injury: from preclinical to clinical neuroprotection?

D Lerouet, C Marchand‐Leroux… - Fundamental & clinical …, 2021 - Wiley Online Library
Traumatic brain injury (TBI) constitutes a major health problem worldwide and is a leading
cause of death and disability in individuals, contributing to devastating socioeconomic …

Research progress on pleiotropic neuroprotective drugs for traumatic brain injury

Q Zhao, H Li, H Li, J Zhang - Frontiers in Pharmacology, 2023 - frontiersin.org
Traumatic brain injury (TBI) has become one of the most important causes of death and
disability worldwide. A series of neuroinflammatory responses induced after TBI are key …

Role of sulfonylurea receptor 1 and glibenclamide in traumatic brain injury: a review of the evidence

RM Jha, J Bell, G Citerio, JC Hemphill… - International journal of …, 2020 - mdpi.com
Cerebral edema and contusion expansion are major determinants of morbidity and mortality
after TBI. Current treatment options are reactive, suboptimal and associated with significant …

Emerging therapeutic targets for cerebral edema

RM Jha, SP Raikwar, S Mihaljevic… - Expert opinion on …, 2021 - Taylor & Francis
Introduction Cerebral edema is a key contributor to death and disability in several forms of
brain injury. Current treatment options are limited, reactive, and associated with significant …

Sulfonylurea receptor 1, transient receptor potential cation channel subfamily M member 4, and KIR6. 2: role in hemorrhagic progression of contusion

V Gerzanich, JA Stokum, S Ivanova, SK Woo… - Journal of …, 2019 - liebertpub.com
In severe traumatic brain injury (TBI), contusions often are worsened by contusion
expansion or hemorrhagic progression of contusion (HPC), which may double the original …

BIIB093 (IV glibenclamide): an investigational compound for the prevention and treatment of severe cerebral edema

M Pergakis, N Badjatia, S Chaturvedi… - Expert opinion on …, 2019 - Taylor & Francis
Introduction: Brain swelling due to edema formation is a major cause of neurological
deterioration and death in patients with large hemispheric infarction (LHI) and severe …